ESTA Valuation

Establishment Labs Holdings Inc

Add to Watchlist

Advanced Chart

34.800

-1.16(-3.226%)1D

Overview
Forecast
Valuation
Earnings

ESTA Relative Valuation

ESTA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ESTA is overvalued; if below, it's undervalued.

Historical Valuation

Establishment Labs Holdings Inc (ESTA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.47 is considered Undervalued compared with the five-year average of -31.75. The fair price of Establishment Labs Holdings Inc (ESTA) is between 167.01 to 200.69 according to relative valuation methord. Compared to the current price of 34.80 USD , Establishment Labs Holdings Inc is Undervalued By 79.16%.

Relative Value

Fair Zone

167.01-200.69

Current Price：34.80

79.16%

Undervalued

-21.05

Trailing

Forward

878.84

EV/EBITDA

Establishment Labs Holdings Inc. (ESTA) has a current EV/EBITDA of 878.84. The 5-year average EV/EBITDA is -83.65. The thresholds are as follows: Strongly Undervalued below -314.17, Undervalued between -314.17 and -198.91, Fairly Valued between 31.60 and -198.91, Overvalued between 31.60 and 146.86, and Strongly Overvalued above 146.86. The current Forward EV/EBITDA of 878.84 falls within the Strongly Overvalued range.

-52.36

EV/EBIT

Establishment Labs Holdings Inc. (ESTA) has a current EV/EBIT of -52.36. The 5-year average EV/EBIT is -47.96. The thresholds are as follows: Strongly Undervalued below -94.62, Undervalued between -94.62 and -71.29, Fairly Valued between -24.63 and -71.29, Overvalued between -24.63 and -1.30, and Strongly Overvalued above -1.30. The current Forward EV/EBIT of -52.36 falls within the Historic Trend Line -Fairly Valued range.

4.47

Establishment Labs Holdings Inc. (ESTA) has a current PS of 4.47. The 5-year average PS is 7.90. The thresholds are as follows: Strongly Undervalued below 2.49, Undervalued between 2.49 and 5.20, Fairly Valued between 10.60 and 5.20, Overvalued between 10.60 and 13.30, and Strongly Overvalued above 13.30. The current Forward PS of 4.47 falls within the Undervalued range.

-67.74

P/OCF

Establishment Labs Holdings Inc. (ESTA) has a current P/OCF of -67.74. The 5-year average P/OCF is -26.06. The thresholds are as follows: Strongly Undervalued below -64.83, Undervalued between -64.83 and -45.45, Fairly Valued between -6.68 and -45.45, Overvalued between -6.68 and 12.70, and Strongly Overvalued above 12.70. The current Forward P/OCF of -67.74 falls within the Strongly Undervalued range.

-90.82

P/FCF

Establishment Labs Holdings Inc. (ESTA) has a current P/FCF of -90.82. The 5-year average P/FCF is -42.05. The thresholds are as follows: Strongly Undervalued below -181.81, Undervalued between -181.81 and -111.93, Fairly Valued between 27.83 and -111.93, Overvalued between 27.83 and 97.71, and Strongly Overvalued above 97.71. The current Forward P/FCF of -90.82 falls within the Historic Trend Line -Fairly Valued range.

Establishment Labs Holdings Inc (ESTA) has a current Price-to-Book (P/B) ratio of 44.20. Compared to its 3-year average P/B ratio of 83.42 , the current P/B ratio is approximately -47.01% higher. Relative to its 5-year average P/B ratio of 60.14, the current P/B ratio is about -26.50% higher. Establishment Labs Holdings Inc (ESTA) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -7.28%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -5.31% , the current FCF yield is about -100.00% lower.

44.20

P/B

Median3y

83.42

Median5y

60.14

0.00

FCF Yield

Median3y

-7.28

Median5y

-5.31

Competitors Valuation Multiple

The average P/S ratio for ESTA's competitors is 75.12, providing a benchmark for relative valuation. Establishment Labs Holdings Inc Corp (ESTA) exhibits a P/S ratio of 4.47, which is -94.05% above the industry average. Given its robust revenue growth of 16.28%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ESTA.O

Establishment Labs Holdings Inc

Integra Lifesciences Holdings Corp

Pulse Biosciences Inc

BioLife Solutions Inc

10.19

28.94%

1.09B

Performance Decomposition

Market capitalization of ESTA decreased by 24.05% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 44.12M to 51.30M.

The secondary factor is the Margin Expansion, contributed -16.92%to the performance.

Overall, the performance of ESTA in the past 1 year is driven by Revenue Growth. Which is more sustainable.

16.28%

44.12M → 51.30M

Revenue Growth

-16.92%

-38.94 → -32.35

Margin Expansion

-23.41%

-14.76 → -11.31

P/E Change

-24.05%